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Design: This study was conducted on 54 female subjects at the
reproductive period. They were divided according to WHO classification
of BMI into two equal groups: Group I (lean group with normal BMI
18.50-24.99kg/m2), and Group II (obese group with BMI 30 - 34.99
kg/m)2, each group was subdivided into: normotensive non-pregnant
group, normotensive pregnant group and preeclamptic group.
Moderate degree of preeclampsia was confirmed by presence of
proteinuria (> 300mg/24h) and hypertension (≥150/100). Placental kiss1
and serum kiss1, insulin, glucose, lipid profile, TNF-α, urea, creatinine
and sex hormones levels were measured. BMI and HOMA-IR were
calculated in all groups.
Results: Serum and placental kiss1 levels were significantly higher in
normotensive pregnant while these levels were significantly lower in
preeclamptic than normotensive pregnant groups and this decrease was
more pronounced in obese than lean subjects. Kiss1 negatively correlated
with blood pressure, BMI, glucose, insulin, HOMA-IR, TC, TG, LDL,
TNF-α and positively correlated with HDL-C, sex hormones.
Conclusion: The decrease in kiss1 levels may play a role in pathogenesis
of PE, and may represent a novel link between metabolic disturbance and
PE in obese pregnant females since this peptide was correlated with BMI,
HOMA-IR, dyslipidemia and TNF-α.
Key word: kiss1, preeclampsia, obesity

INTRODUCTION
reeclampsia (PE) is a pregnancy-specific
syndrome .It is a leading cause of
maternal morbidity and mortality, with a

P
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worldwide prevalence of 2–10%. Obesity is a
state of chronic, low-grade inflammation and
that pro-inflammatory status mediate the
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development of placental ischemia-induced
hypertension[1].
Although the primary mechanism of
preeclampsia is still unknown, it is
characterized by impaired placental function,
abnormal trophoblast invasion, deficient
physiologic
maternal
spiral
artery
modification,
increased
apoptosis
of
trophoblastic cells and placental ischemia
.Interestingly a number of factors have been
implicated in trophoblast invasion, such as
kisspeptin[2].
Kisspeptin is a peptide encoded by the
kiss1 gene, binds to G protein-coupled
receptor 54 (GPR54) (kiss1r)[3].Both kiss-1
and kiss-1r mRNA are expressed centrally in
the brain, spinal cord, hypothalamus, and
peripherally in the placental trophoblast,
overies, pancreatic cells, liver and adipose
tissue [4].
It was proposed that increase in the total
number of trophoblast cells throughout the
course of gestation is responsible for the
dramatic increase in serum kiss1 levels
examined especially in the third trimester
Dysregulation of the kiss1may negatively
affect the processes of implantation as well as
placentation [5]. Also its role in regulating
body weight and glucose homeostasis was
reported [6].
In preeclamptic women, Ziyaraa et al.[3]
found a marked decrease in plasma kiss1
levels when compared with normotensive
pregnant women .In contrast, other
investigators showed either no difference [7] in
circulating kiss1 levels or a significantly high
level in preeclamptic patients when compared
with normotensive controls [8]. Moreover,
several studies have reported elevated Kiss-1
mRNA, protein and kiss1r expression in
trophoblasts and preeclamptic placenta[9],
while other studies found no difference in
placental Kiss1r mRNA and protein
expression between healthy and preeclamptic
pregnancies. .In addition to tissue expression
studies, decreased maternal serum kiss1 levels
in early pregnancy have been associated with
development of preeclampsia[10].
On the hand, there were contradictory
reports about the circulating levels of kiss1 in
obese women. While Kołodziejski et al.[12]
Ali K., et al
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found lower kiss1 concentrations in obese
women and observed a negative correlation
between kiss1 and BMI, Çelik et al.[13] found
no significant difference in kiss1 levels in
overweight and obese women compared with
normal-weight women and observed no
correlation between kiss1 and BMI.
This study was designed to evaluate
serum and placental kiss1 levels in
normotensive non-pregnant, pregnant and
preeclamptic females and to detect any
potential association of those levels with
some homeostatic parameters occurring in
these conditions with and without obesity
SUBJECTS AND METHODS
 Subjects :
This study was a case control study that
was conducted on 54 female patients their
ages ranging between 20-35 years. They were
Chosen from the out-patient clinics and
inpatients department of Obstetrics and
Gynecology- Zagazig University Hospitals
after obtaining the required authorities’
permissions .It was done during the period
from Novamber 2017 to December 2018. The
study design was approved by the
Institutional Review Board (IRB) NO.305014-12-2016, Faculty of Medicine, Zagazig
University.
Written informed consent was obtained
from all participants and the study was
approved by the research ethical committee of
Faculty of Medicine, Zagazig University. The
work has been carried out in accordance with
The Code of Ethics of the World Medical
Association (Declaration of Helsinki) for
studies involving humans. Women included
in this study were divided according WHO
[13]
classification of BMI into two equal
groups:
Group I (lean group with normal BMI (18.5024.99kg/m2)(n=27)) subdivided into:
Group Ia (normotensive non-pregnant group),
Group Ib (normotensive pregnant group) and
Group Ic (pregnant preeclamptic group).
Group II (obese group with BMI (30 - 34.99
kg/m2)( n=27)) subdivided into:
Group IIa (normotensive non-pregnant
group), Group IIb (normotensive pregnant
group) and Group IIc (pregnant preeclamptic
group).
344 | P a g e
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Inclusion criteria:
 The preeclamptic women included in the
study were considered to have moderate preeclampsia according to the criteria established
by the Royal College of Obstetricians and
Gynecologists (ACOG)[14] if they have:
 A systolic blood pressure of ≥150mmHg
&<160 mmHg and/ or diastolic blood
pressure of ≥100mmHg & <110 mmHg on
two occasions at least 6 hours apart, typically
occurring after 20 weeks gestation (no more
than 1 week apart)
 In conjunction with new onset proteinuria of
> 300 mg/24h urine collection or > 1+ on two
random sample urine dipsticks at least 6 hours
apart (no more than 1 week apart).



The non-preeclamptic women included in
the study were:

 Non- pregnant women non-lactating who had
regular menstrual cycle (28 - 33 days), in the
follicular phase of the menstrual cycle and no
use of prescription medications (including
hormonal contraception) for at least 2 months
before the study
 Pregnant women with gestational age greater
than 20 weeks with single pregnancy.
Exclusion criteria:
 Women with comorbidities including
metabolic, vascular, and systemic diseases as:
diabetes, chronic hypertension, proteinuria or
urinary tract infection.
 Women who have multiple pregnancies or in
labor.
 Patients with severe preeclampsia (BP ≥
160/110 mmHg with proteinuria 2.0 g/24
hours or ≥ +2 dipsticks in the absence of
urinary tract infection).
 Patients who have previous bad obstetric
history or obstetric complications of the
current pregnancy.
Data collection
All preeclamptic pregnant women were
hospitalized, while for the normotensive nonpregnant groups. Samples were collected
from out-patient clinics and the normotensive
pregnant women during routine antenatal
visits after the 20th week gestational age that
was derived from the last menstrual period
and
was
corrected
according
to
transabdominal
and/or
transvaginal
ultrasonography if needed.
Ali K., et al
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In all groups blood pressure was
measured with the patients in a seated
position and with the cuff of the
sphygmomanometer at the level of the heart,
body weight and height were measured and
BMI was calculated by using the formula of
kg/m2 .A urine sample was taken and
proteinuria was determined according to the
method of Dilena et al.[15] .
A venous blood sample was withdrawn
at 9.00 a.m. following overnight fasting.
Samples were taken into standard serum
tubes, allowed to clot, then serum was
separated by centrifugation at 3000 rpm for
15 minutes and stored frozen at -20 ºC until
assayed for: kisspeptin according to
(manufacturer instructions), urea according
to Kaplan.[16], creatinine according to
Murray.[17], insulin according to Temple et
al.[18],HDL-C according to Nauck et al.[19],
triglyceride (TG) according to Fossati.[20],
total cholesterol, glucose, estrogen and
progesterone according to Tietz. [21]. TNF-α
according to Fernando et al.[22] LDL was
calculated as follows: LDL=TC-HDLC-TG/5
.also, HOMA-IR was calculated as follows
insulin (µU/mL) x glucose (mg/dl) /405.
Tissue sampling:
The placenta was sampled at the time of
delivery then washed by saline; cut into small
pieces homogenized in 5-10 ml cold buffer,
and then was centrifuged at the speed of
2000-3000 r.p.m. for at 20 minutes. After that
the supernatant was removed for assaying the
kisspeptin level in the placental tissue
according to Cirelli et al.[23] method.
Statistical analysis:
Data were presented as mean ± SD
Statistical analysis of differences between
groups was determined by a one-way analysis
of variance (ANOVA) and the correlations
between the parameters were analysed using
pearson correlation (r). P<0.05 was
considered statistically significant. SPSS
Version 18.0.0 software package (SPSS Inc.
Chicago, IL, USA) was used.
RESULTS
Serum kiss1 levels were significantly
higher in normotensive pregnant groups
(Ib&IIb) than non- pregnant groups (Ia&IIa)
(P< 0.0001). These high levels were
345 | P a g e
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accompanied by significant high levels of
insulin, HOMA-IR, total cholesterol (TC),
triglyceride (TG), low density lipoprotein
(LDL), high density lipoprotein (HDL), TNFα , sex hormones and BMI but serum
glucose, urea and creatinine levels were
significantly lower (table1&2) .
Serum kiss1 levels were significantly
lower in preeclamptic groups (Ic&IIc) than
normotensive pregnant groups (Ib&IIb) (P<
0.0001). These low levels were accompanied
by significant increase in levels of insulin,
HOMA-IR, TC, TG, LDL, TNF-α, urea,
creatinine in addition to blood pressure and
BMI but they were associated with a
significant decrease in serum levels of HDL
and sex hormones. The previously mentioned
changes were more pronounced in obese

groups (IIa,IIb,IIc) as compared with lean
groups (Ia,Ib,Ic) (table1&2)
Moreover, in all studied groups, There
was a significant negative correlation
(P<0.05) between serum kiss1 level and BMI
, serum glucose, insulin ,HOMA-IR , total
cholesterol, TG, LDL,TNF-α & blood
pressure, while
there was a significant
positive correlation (P<0.05) between serum
kiss1 levels and serum levels of HDL-C
&sex hormones (table3).
Regarding placental levels of kiss1, there was
a significant decrease (p < 0.0001) in its
levels in lean preeclamptic females as
compared to lean normotensive pregnant
groups, furthermore this decrease was more
pronounced in obese preeclamptic groups
(figure
1).

Table (1): Clinical and laboratory data of all studied groups
Lean group

Obese group

Group Ia
Group Ib
(lean non- (lean
pregnant)
normotensiv
e pregnant)
4944±1005*
kiss1 640.44±95

Serum
(pg/ml)
Maternal
age
(years)
Gestational age
(weeks)
BMI(kg/m2)
SBP(mmHg)
DBP(mmHg)
Proteinuria
(mg/24h)
Urea (mg/dl)
Creatinine
(mg/dl)

Group Ic
(lean
preeclamptic

26.7±2.3

27.2±1.9

2227.44
489$
28.1±2.6

─

30.44 ± 2.78

23.33 ± 1.26
106.6 ± 10
69.44 ± 6.82
─
23.65 ± 2.32
0.96 ± 0.06

Group IIa
Group IIb
(obese non- (obese
pregnant)
normotensive
pregnant)
*
± 103 ± 5.16
3707 ± 457$,**

Group IIc
(obese
preeclamptic)
1394± 152@,#

26.72±2.3

28.31±2.6

27.5±1.6

30 ± 2.73

─

30.77 ± 2.77

30.55 ± 3.12

28.22 ±1.04*
105 ± 5.59
67.77± 7.12
0.0±0.0

29.89 ± 1.97
152 ±2$
101.66 ± 2.39$
1044.4±406.5$

33.11± 1.33*
116.66 ±5.5*
75.88 ± 7.2*
─

37 ± 1.47$,**
111.6 ± 6.12$
73.88± 6.51$
0.0±0.0

39.71 ± 2.07@,#
158± 0.71@,#
107.66 ± 1.22@,#
1255.55±335.8#

18.8 ± 2.5*
0.68 ± 0.19*

37.15 ± 1.5$
1.04 ± 0.13$

25.48 ± 2.6
0.94 ± 0.07

20.3 ± 3.24**
0.8 ± 0.13**

36.98± 6.32#
1.14 ± 0.16#

*=Significant vs Ia $= Significant vs Ib @=Significant vs Ic **= Significant vs IIa
#=
Significant vs IIb
Kiss1 (kisspeptin), SBP (systolic blood pressure), DBP (diastolic blood pressure), BMI (body mass
index) .
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Table (2): The mean value ± SD of metabolic, inflammatory and hormonal parameters measured in
all studied groups
Lean group

Group Ia
(lean nonpregnant)
FBG(mg/dl)
Insulin(µIu/ml)
HOMA-IR
TC(mg/dl)
HDL-C(mg/dl)
TG(mg/dl)
LDL-C(mg/dl)
TNF-α(pg/ml)
Esterogen
(pg/ml)
Progesterone
(ng/ml)

Obese group

Group Ic
(lean
preeclamptic

Group IIa
(obese nonpregnant)

93.56 ± 6.42
4.61 ± 1.05
1.06 ± 0.26
176± 15.84
51.22 ± 3.41
119.56± 16.2
101.31 ±15.6
15.88 ± 1.26
129.6 ± 0.71

Group Ib
(lean
normotensive
pregnant)
80.56 ± 4.56*
11.04 ± 1.81*
2.21 ± 0.48*
265.66 ± 39*
61.77 ± 3.07*
231.8 ± 32.8*
157.53± 30*
19.88 ± 2.57*
5004.4±75.7*

Group IIc
(obese
preeclamptic)

108.6 ± 8*
13.17 ± 1*
3.55 ± 0. 50*
220.33 ± 22*
45.55 ± 3.9*
167.11 ± 37*
141.36±15*
36.3 ± 3.39*
31.11± 1.53*

Group IIb
(obese
normotensive
pregnant)
89.67 ± 3.2$,**
19.14 ± 2.2$,**
4.24 ± 0.52$,**
357.33 ±60$,**
54.3 ± 3.08$,**
319.1±46.7$,**
239.17± 51$,**
41 ± 3.93$,**
4860.6±145$,**

79.33±7.22$
13.26 ± 1.82$
2.62 ± 0.56$
317.88 ± 46$
43 ± 2.78$
277.56 ± 32.8$
219.38± 40.9$
39.44 ± 2.18$
3648.11±110$

8.20 ± 1.48

279.66±13.6*

81.36 ± 9.24$

8.62 ± 2.83*

173.36±15$,**

41.95 ± 7.15@,#

90.22 ± 3.26@
22.54 ± 4@,#
5.05 ± 1.03@,#
443.11 ± 52.9@,#
32.64 ± 1.99@,#
415.22 ± 43.2@,#
327.42±45.65@,#
56.77 ± 5.65@,#
3044.78±144@,#

*=Significant vs Ia $= Significant vs Ib @=Significant vs Ic **= Significant vs IIa
#=
Significant vs IIb
FBG (fasting blood glucose level), TC (total cholesterol), HDL-C (high density lipoproteincholesterol), TG (triglyceride) LDL-C (low density lipoprotein- cholesterol), TNF-α (tumor
necrosis factor alpha)
Table (3): Correlation between serum kiss1 levels and all studied parameters in all groups
Lean group

BMI
SBP
DBP
Urea
Creatinine
FBG
Insulin
HOMA-IR
TC
HDL-C
TG
LDL-C
TNF-α
Esterogen
Progesterone

Group Ia
Group Ib
(lean non- (lean
pregnant)
normotensiv
e pregnant)
r
r
-0.795*
-0.900**
-0.903**
-0.804**
-0.920**
-0.919**
-0.053
-0.122
-0. 228
0.439
-0.824**
-0.970**
-0.964**
-0.939**
-0.906**
-0.965**
-0.924**
-0. 925**
0.958**
0.947**
-0.890**
-0.844**
-0.934**
-0.940**
-0.833**
-0.917**
0.873**
0.880**
0.967**
0.912**

Obese group
Group Ic
(lean
preeclamp
tic
r
-0.904**
-0.712*
-0.797*
0.394
0.122
-0.832**
-0.822**
-0.906**
-0.888**
0.858**
-0.901**
-0.779*
-0.833**
0.866**
0.849**

Group IIa
Group IIb
(obese
non- (obese
pregnant)
normotensiv
e pregnant)
r
r
-0.943**
-0.797*
-0.680*
-0.849**
-0.842**
-0.723*
-0.559
0.402
-0.026
0.372
-0.992**
-0. 937**
-0.898**
-0.681*
-0.975**
-0.701*
-0.962**
-0.951**
0.920**
0.972**
-0. 976**
-0.907**
-0.840**
-0.890**
-0.925**
-0.984**
0.878**
0.947**
0.923**
0.955**

Group IIc
(obese
preeclampti
c)
r
-0.977**
-0.927**
-0.898**
-0.044
-0.399
-0.953**
-0.683*
-0.917**
-0.993**
0.915**
-0.943**
-0. 989**
-0.905**
0.914**
0.819**

r: correlation coefficient *:correlation is significant at p< 0.05 **:correlation is significant at
p< 0.01
Ali K., et al
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Figure (1): Placental kiss1 levels (pg/gm of tissue) in normotensive pregnant
and preecalmptic groups
@=Significant vs Ic
#= Significant vs IIb
$=Significant vs Ib
DISCUSSION
This study was designed to evaluate
serum and placental kiss1 levels in
normotensive non-pregnant, pregnant and
preeclamptic females and to detect any
potential association of those levels with
some homeostatic parameters occurring in
these conditions with and without obesity
Regarding serum kiss1, there was a
significant increase in its levels in pregnant
groups (Ib &IIb) compared with nonpregnant groups (Ia &IIa). However, these
levels were significantly decreased in
preeclamptic groups (Ic &IIc) as compared to
normotensive- pregnant groups.
Our results can be explained by those of
Hu et al. [4]who reported that increased total
number of trophoblast cells throughout the
course of gestation is responsible for the
dramatic increase in serum kiss1 levels
examined .Also, they concluded that
dysregulation of the kiss1 system may
negatively
affect
the
processes
of
implantation as well as placentation. This
notion supports our results of decreased
serum kiss1 levels in preeclamptic groups.
Moreover, other investigators reported
marked decrease of plasma kiss1 in PE
Ali K., et al
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patients when compared with normotensive
controls[3,9] .Furthermore Wu et al.[24]
suggested that kiss1 may modulate embryo
implantation and decidual programming in
human pregnancy via the focal adhesion
kinase (FAK)–steroid receptor coactivator
intracellular tyrosine kinases pathway.
In contrast to these data, Nijher et al.
[6]
did not find any difference in circulating
kiss1 levels between preeclamptic women and
trimester-matched normotensive controls,
while Vazquez-Alaniz et al. [7] reported high
levels of kiss in preeclampsia patients.
Furthermore in the present work, there
was a significant decrease in serum and
placental kiss1levels in obese groups as
compared to that of lean groups. There was
also a significant negative correlation between
serum kiss1level and BMI in all studied
groups. These findings are in agreement with
Kołodziejski et al. [11] who found lower kiss1
concentrations in obese women compared to
lean and observed a negative correlation
between kiss1 and BMI. In addition, Logie et
al.[25] demonstrated that plasma kiss1 levels
were significantly lower in obese pregnant
compared with lean pregnant women. In
contrast to our results, some investegators
348 | P a g e
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found no significant difference in kiss1 levels
in overweight and obese females compared
with normal-weight females. Also, observed
no correlation between circulating kiss1 levels
and BMI [12].
In the present study, pregnant women
showed significantly higher serum insulin
levels and HOMA-IR index when compared
with non-pregnant women, while there was a
significant decrease in serum blood glucose
levels in the same group.
As regards lipid profile, our study
showed a significant increase in serum levels
of total cholesterol, HDL, TG, LDL, VLDL in
pregnant groups when compared with nonpregnant groups. These results are supported
by many studies that reported higher level of
lipid profile in pregnant women [1] .
Furthermore, in our study obese
subjects
(groupIIa,IIb,IIc)
showed
significantly higher serum levels of glucose
and insulin in addition to HOMA-IR index
when compared with lean subjects
(groupIa,Ib,Ic). Moreover, the levels of serum
TC, TG and LDL were significantly
increased, while, there was a significant
decrease in HDL levels in the same group.
These results are in line with those of Scifres
et al.[26] who found that overweight/obese
women have significantly more atherogenic
lipid profiles than normal weight women and
observed that in all types of hyperlipidemia,
there was lowering of insulin sensitivity.
Decreased
serum
kiss1
levels
encountered in the present study may play a
crucial role in the metabolic alterations
linking obesity via changes in IR, lipid profile
and adipocytokine. Our results showed a
significant negative correlation between
serum kiss1 level and serum levels of glucose,
insulin and HOMA-IR in all groups. These
results are in accordance with those of other
investigators who explored the negative
associations between kiss1 levels and obesity,
dyslipidemia &IR[11].
Insulin resistance is one of the major
causes of dyslipidemia .Our results showed a
significant negative correlation between
serum kiss1 level and serum levels of TC,
TG, LDL in all groups, while there was a
significant positive correlation between serum
Ali K., et al
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kiss1 and HDL levels in all studied groups.
Kołodziejski et al.[11] found negative
correlation between kiss1 and leptin and a
positive one with adiponectin as determinants
of insulin resistance and obesity. leptin has a
pro-inflammatory activity and increases IR
while adiponectin has reversed effect.
The results of the present study showed
non-significant changes in systolic and
diastolic blood pressure in pregnant groups as
compared
with
non-pregnant
groups.
However, blood pressure was significantly
higher in preelamptic groups as compared
with pregnant and in obese groups when
compared with non-obese groups. A
significant negative correlation between kiss1
and systolic & diastolic blood pressure were
found in all groups. These finding are in line
with those of Logie et al.[25] who found
strong negative
associations
between
circulating kiss1 in pregnancy and blood
pressure. Our results are also supported by
those of Bedenbaugh et al.[27] who reported
that NO release may be influenced directly by
kiss1. Moreover, Mezei et al.[28] suggested
that kiss1, through the alteration of eicosanoid
synthesis in platelets and aorta, may play a
role in the regulation of vascular tone.
The results in the present work revealed
significant increase in serum levels of
estrogen and progesterone in pregnant groups
(Ib&IIb) when compared with non-pregnant
groups (Ia&IIa) .However, their levels were
significantly decreased in preelamptic groups
as compared with pregnant and in obese
groups when compared with non-obese
groups. Furthermore, there was a significant
positive correlation between kiss1 and
estrogen & progesterone in all groups. This is
in agreement with the results of other
studies[29].
In the present study, there was a
significant increase in serum level of TNF-α
in pregnant groups (Ib&IIb) when compared
with non- pregnant groups (Ia&IIa).Moreover
this increase was more profound in obese
preeclamptic women than other groups and
there was a negative significant correlation
between kiss1 and TNF-α in all groups These
results are in accordance with those of other
studies that found elevated maternal
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circulating TNF-α and IL-6 levels with high
predictive
values
for
preeclampsia
[2].
However, these findings are in contrast to
those of Afshari et al.[30] who showed that
serum TNF-α level was not associated with
preeclampsia.
Kiss1 and Kiss1r mRNAs have been
detected in the peripheral blood leukocytes
and lymphocytes. Moreover, kiss1/kiss1r
efficiently suppressed the activation of PI3
kinase (PI3K)-Akt pathway by receptor
tyrosine kinases (RTKs), resulting in the
inhibition of cytokines. The reverse will occur
when circulating kiss1 levels are decreased as
observed in obese and preeclamptic women of
the present study and other studies[31].
Therefore, reduction in circulating kiss1
levels may be a cause or a result of the
inflammatory process encountered in obesity
and PE
Conclusion: The present study revealed that
placental and serum kiss1 levels were
significantly increased during normal
uncomplicated pregnancy while significantly
decreased during pregnancy complicated with
PE either in lean or obese women, however,
this decrease was more exaggerated in obese.
Moreover, kiss1 may play a role in
pathogenesis of PE and its associated
metabolic, hormonal and proinflammatory
changes.
Recommendation: Further studies are
required to clarify the possible benefit of
using kiss1 and/or anti-TNF α treatment in
PE.
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